Galmed Pharmaceuticals (GLMD) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Galmed Pharmaceuticals Ltd. has entered into a sales agreement with JonesTrading Institutional Services LLC, allowing the company to issue and sell ordinary shares at their discretion. This strategic move signals Galmed’s effort to leverage market opportunities and could potentially impact its stock value as shares are sold in at-the-market offerings.
For further insights into GLMD stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue